{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:51:56Z","timestamp":1790790716279,"version":"4.1.0"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.nbd.2020.104760","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T11:42:54Z","timestamp":1579606974000},"page":"104760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Immunotherapy for Parkinson\u2019s disease"],"prefix":"10.1016","volume":"137","author":[{"given":"Aaron D.","family":"Schwab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie J.","family":"Thurston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Machhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Namminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-0370","authenticated-orcid":false,"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Lee","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104760_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-140491","article-title":"Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease","volume":"5","author":"Allen Reish","year":"2015","journal-title":"J Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104760_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2016.02.006","article-title":"Therapies targeting lipid peroxidation in traumatic brain injury","volume":"1640","author":"Anthonymuthu","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104760_bb0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(11)60980-X","article-title":"Anti-CD3 antibodies for type 1 diabetes: beyond expectations","volume":"378","author":"Bach","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2020.104760_bb0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2017.12.012","article-title":"Emerging trends in the immunotherapy of pancreatic cancer","volume":"417","author":"Banerjee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.nbd.2020.104760_bb0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(00)00422-7","article-title":"Lymphocyte populations in Parkinson\u2019s disease and in rat models of parkinsonism","volume":"113","author":"Bas","year":"2001","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0035","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0040","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1073\/pnas.0400569101","article-title":"Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"101","author":"Benner","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.nbd.2020.104760_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001376","article-title":"Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons","volume":"3","author":"Benner","year":"2008","journal-title":"PLoS One."},{"key":"10.1016\/j.nbd.2020.104760_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0310154","article-title":"GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms","volume":"89","author":"Bhattacharya","year":"2011","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.nbd.2020.104760_bb0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/jir.2014.0149","article-title":"Dual role of GM-CSF as a pro-inflammatory and a regulatory cytokine: Implications for immune therapy","volume":"35","author":"Bhattacharya","year":"2015","journal-title":"J Interferon Cytokine Res."},{"key":"10.1016\/j.nbd.2020.104760_bb0060","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1523\/JNEUROSCI.4364-04.2005","article-title":"Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson\u2019s disease","volume":"25","author":"Boska","year":"2005","journal-title":"J Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0065","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nbd.2020.104760_bb0070","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","article-title":"6-Hydroxydopamine-induced alterations in blood-brain barrier permeability","volume":"22","author":"Carvey","year":"2005","journal-title":"Eur J Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0075","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/0277-5379(90)90053-V","article-title":"The effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor","volume":"26","author":"Cebon","year":"1990","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.nbd.2020.104760_bb0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/eji.1830121116","article-title":"Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody","volume":"12","author":"Chatenoud","year":"1982","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0085","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.3892\/mmr.2015.4136","article-title":"Clinical correlation of peripheral CD4+cell subsets, their imbalance and Parkinson\u2019s disease","volume":"12","author":"Chen","year":"2015","journal-title":"Mol Med Rep."},{"key":"10.1016\/j.nbd.2020.104760_bb0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/ars.2011.3960","article-title":"NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson\u2019s disease","volume":"16","author":"Choi","year":"2012","journal-title":"Antioxid Redox Signal."},{"key":"10.1016\/j.nbd.2020.104760_bb0095","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1073\/pnas.0504484102","article-title":"Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders","volume":"102","author":"Chorny","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.nbd.2020.104760_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45433-3","article-title":"The characterization of regulatory t-cell profiles in alzheimer's disease and multiple sclerosis","volume":"9","author":"Ciccocioppo","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.nbd.2020.104760_bb0105","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.nbd.2020.104760_bb0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.nbd.2020.104760_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-017-0297-z","article-title":"Alzheimer\u2019s disease prevention: from risk factors to early intervention","volume":"9","author":"Crous-Bou","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.nbd.2020.104760_bb0125","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.freeradbiomed.2008.03.005","article-title":"Oxidative and nitrative protein modifications in Parkinson\u2019s disease","volume":"44","author":"Danielson","year":"2008","journal-title":"Free Radic Biol Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0130","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2020.104760_bb0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1474-4422(08)70099-1","article-title":"Non-autonomous cell death in Parkinson\u2019s disease","volume":"7","author":"Dawson","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0140","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0145","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1189\/jlb.0605299","article-title":"Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo","volume":"78","author":"Delgado","year":"2005","journal-title":"J Leukoc Biol."},{"issue":"1207\u20131217","key":"10.1016\/j.nbd.2020.104760_bb0150","article-title":"Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn\u2019s disease","volume":"143","author":"Desreumaux","year":"2012","journal-title":"Gastroenterology."},{"key":"10.1016\/j.nbd.2020.104760_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1570159X14666151120123025","article-title":"Current pharmaceutical treatments and alternative therapies of Parkinson\u2019s disease","volume":"14","author":"Dong","year":"2016","journal-title":"Curr Neuropharmacol."},{"key":"10.1016\/j.nbd.2020.104760_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/neu.2015.4373","article-title":"Glutamate neurotransmission in rodent models of traumatic brain injury","volume":"34","author":"Dorsett","year":"2017","journal-title":"J Neurotrauma."},{"key":"10.1016\/j.nbd.2020.104760_bb0170","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0175","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104760_bb0180","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","article-title":"Calcium entry and alpha-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons","volume":"33","author":"Dryanovski","year":"2013","journal-title":"J Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/152308603322110896","article-title":"Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson\u2019s disease","volume":"5","author":"Ebadi","year":"2003","journal-title":"Antioxid Redox Signal."},{"key":"10.1016\/j.nbd.2020.104760_bb0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000362719","article-title":"Imaging of acute ischemic stroke","volume":"72","author":"El-Koussy","year":"2014","journal-title":"Eur Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0195","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1126\/science.2567056","article-title":"The role of excitatory amino acids and NMDA receptors in traumatic brain injury","volume":"244","author":"Faden","year":"1989","journal-title":"Science."},{"issue":"1\u20139","key":"10.1016\/j.nbd.2020.104760_bb0200","article-title":"Comparative review of adult midbrain and striatum neurogenesis with classical neurogenesis","volume":"134","author":"Farzanehfar","year":"2018","journal-title":"Neurosci Res."},{"key":"10.1016\/j.nbd.2020.104760_bb0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2020.104760_bb0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/eji.200535430","article-title":"Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis","volume":"36","author":"Fernandez-Martin","year":"2006","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1755-5949.2010.00145.x","article-title":"A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson\u2019s disease","volume":"16","author":"Ferreira","year":"2010","journal-title":"CNS Neurosci Ther."},{"key":"10.1016\/j.nbd.2020.104760_bb0220","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","article-title":"Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay","volume":"70","author":"Floor","year":"1998","journal-title":"J Neurochem."},{"key":"10.1016\/j.nbd.2020.104760_bb0225","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science."},{"key":"10.1016\/j.nbd.2020.104760_bb0230","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0963689717714102","article-title":"Traumatic brain injury: current treatment strategies and future endeavors","volume":"26","author":"Galgano","year":"2017","journal-title":"Cell Transplant."},{"key":"10.1016\/j.nbd.2020.104760_bb0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/intimm\/dxn147","article-title":"GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis","volume":"21","author":"Ganesh","year":"2009","journal-title":"Int Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0240","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","article-title":"Autoimmunity in parkinson\u2019s disease: the role of alpha-synuclein-specific T cells","volume":"10","author":"Garretti","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson's disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J Immunol Res."},{"key":"10.1016\/j.nbd.2020.104760_bb0250","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11481-015-9639-4","article-title":"A perspective on roles played by innate and adaptive immunity in the pathobiology of neurodegenerative disorders","volume":"10","author":"Gendelman","year":"2015","journal-title":"J Neuroimmune Pharmacol."},{"key":"10.1016\/j.nbd.2020.104760_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-017-0013-5","article-title":"Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson\u2019s disease trial","volume":"3","author":"Gendelman","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104760_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0265","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40263-013-0077-7","article-title":"The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer\u2019s disease taking cholinesterase inhibitors","volume":"27","author":"Grossberg","year":"2013","journal-title":"CNS Drugs."},{"key":"10.1016\/j.nbd.2020.104760_bb0270","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12035-013-8517-4","article-title":"Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson\u2019s disease?","volume":"49","author":"Gupta","year":"2014","journal-title":"Mol Neurobiol."},{"key":"10.1016\/j.nbd.2020.104760_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.07.002","article-title":"The role of retinoic acid in tolerance and immunity","volume":"35","author":"Hall","year":"2011","journal-title":"Immunity."},{"key":"10.1016\/j.nbd.2020.104760_bb0280","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0285","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","article-title":"Oxidative stress induces amyloid-like aggregate formation of NACP\/alpha-synuclein in vitro","volume":"10","author":"Hashimoto","year":"1999","journal-title":"Neuroreport."},{"key":"10.1016\/j.nbd.2020.104760_bb0290","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","article-title":"The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson\u2019s disease","volume":"41","author":"Hastings","year":"2009","journal-title":"J Bioenerg Biomembr."},{"key":"10.1016\/j.nbd.2020.104760_bb0295","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.3233\/JPD-181488","article-title":"Repairing the brain: Cell Replacement using stem cell-based technologies","volume":"8","author":"Henchcliffe","year":"2018","journal-title":"J Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104760_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1076\/jhin.11.1.19.9106","article-title":"Friedrich Heinrich Lewy (1885-1950) and his work","volume":"11","author":"Holdorff","year":"2002","journal-title":"J Hist Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0305","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.redox.2017.11.010","article-title":"Integrin CD11b mediates alpha-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.nbd.2020.104760_bb0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2362.1992.tb01934.x","article-title":"Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF","volume":"22","author":"Hovgaard","year":"1992","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/j.nbd.2020.104760_bb0315","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","volume":"366","author":"Howard","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0320","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nbd.2020.104760_bb0325","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/NDT.S2006","article-title":"Current approaches to the treatment of Parkinson\u2019s disease","volume":"4","author":"Jankovic","year":"2008","journal-title":"Neuropsychiatr Dis Treat."},{"key":"10.1016\/j.nbd.2020.104760_bb0330","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","article-title":"Neuroimmunology of traumatic brain injury: time for a paradigm shift","volume":"95","author":"Jassam","year":"2017","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2020.104760_bb0335","series-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects","article-title":"Immunogenetics of Parkinson\u2019s disease","author":"Jimenez-Ferrer","year":"2018"},{"key":"10.1016\/j.nbd.2020.104760_bb0340","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","article-title":"Stroke injury, cognitive impairment and vascular dementia","volume":"1862","author":"Kalaria","year":"2016","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.nbd.2020.104760_bb0345","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2020.104760_bb0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JPD-130250","article-title":"The role of innate and adaptive immunity in Parkinson\u2019s disease","volume":"3","author":"Kannarkat","year":"2013","journal-title":"J Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104760_bb0355","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymthe.2017.09.001","article-title":"Gene therapy-induced antigen-specific Tregs inhibit neuro-inflammation and reverse disease in a mouse model of multiple sclerosis","volume":"26","author":"Keeler","year":"2018","journal-title":"Mol Ther."},{"key":"10.1016\/j.nbd.2020.104760_bb0360","first-page":"4284","article-title":"Bridge between neuroimmunity and traumatic brain injury","volume":"20","author":"Kelso","year":"2014","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.nbd.2020.104760_bb0365","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jneuroim.2014.11.002","article-title":"Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma","volume":"278","author":"Kelso","year":"2015","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0370","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","article-title":"Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia","volume":"20","author":"Kim","year":"2000","journal-title":"J Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0375","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat Commun."},{"key":"10.1016\/j.nbd.2020.104760_bb0380","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2018.03.009","article-title":"Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer\u2019s disease mice","volume":"319","author":"Kiyota","year":"2018","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0385","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol Rev."},{"key":"10.1016\/j.nbd.2020.104760_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122756","article-title":"Adjunctive therapy approaches for ischemic stroke: innovations to expand time window of treatment","volume":"18","author":"Knecht","year":"2017","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.nbd.2020.104760_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/823902","article-title":"Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson\u2019s disease","volume":"2012","author":"Koppula","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.nbd.2020.104760_bb0400","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0405","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa041109","article-title":"Sargramostim for active Crohn\u2019s disease","volume":"352","author":"Korzenik","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0410","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1471-4159.2010.06834.x","article-title":"Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases","volume":"114","author":"Kosloski","year":"2010","journal-title":"J Neurochem."},{"key":"10.1016\/j.nbd.2020.104760_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","article-title":"GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice","volume":"265","author":"Kosloski","year":"2013","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0420","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0425","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/imt-2016-0049","article-title":"Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside","volume":"8","author":"Kuhn","year":"2016","journal-title":"Immunotherapy."},{"key":"10.1016\/j.nbd.2020.104760_bb0430","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0435","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001199-200609000-00001","article-title":"The epidemiology and impact of traumatic brain injury: a brief overview","volume":"21","author":"Langlois","year":"2006","journal-title":"J Head Trauma Rehabil."},{"key":"10.1016\/j.nbd.2020.104760_bb0440","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3233\/JPD-179006","article-title":"The MPTP Story","volume":"7","author":"Langston","year":"2017","journal-title":"J Parkinsons Dis."},{"key":"10.1016\/j.nbd.2020.104760_bb0445","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2020.104760_bb0450","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/273059a0","article-title":"Receptor basis for dopaminergic supersensitivity in Parkinson\u2019s disease","volume":"273","author":"Lee","year":"1978","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2020.104760_bb0455","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0460","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/intimm\/dxq001","article-title":"GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells","volume":"22","author":"Liao","year":"2010","journal-title":"Int Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2020.104760_bb0465","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1471-2091-8-S1-S13","article-title":"Role of the ubiquitin proteasome system in Parkinson\u2019s disease","volume":"8","author":"Lim","year":"2007","journal-title":"BMC Biochem."},{"key":"10.1016\/j.nbd.2020.104760_bb0470","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coi.2019.07.004","article-title":"Roles for the adaptive immune system in Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"59","author":"Lindestam Arlehamn","year":"2019","journal-title":"Curr Opin Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0475","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/abbs\/gmr007","article-title":"PGC-1 coactivators in the control of energy metabolism","volume":"43","author":"Liu","year":"2011","journal-title":"Acta Biochim Biophys Sin (Shanghai)."},{"key":"10.1016\/j.nbd.2020.104760_bb0480","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3389\/fimmu.2019.01265","article-title":"Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update","volume":"10","author":"Lotfi","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0485","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat Rev Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0490","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","article-title":"Moderate and severe traumatic brain injury in adults","volume":"7","author":"Maas","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0495","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaci.2003.08.015","article-title":"Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF","volume":"112","author":"Martinez-Moczygemba","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0500","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson\u2019s disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov Disord."},{"key":"10.1016\/j.nbd.2020.104760_bb0505","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410240415","article-title":"Rate of cell death in parkinsonism indicates active neuropathological process","volume":"24","author":"McGeer","year":"1988","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0510","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nm1752","article-title":"Dopamine neurons implanted into people with Parkinson\u2019s disease survive without pathology for 14 years","volume":"14","author":"Mendez","year":"2008","journal-title":"Nat Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0515","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0520","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1474-4422(17)30276-4","article-title":"T cells and Parkinson\u2019s disease","volume":"16","author":"Mosley","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0525","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009381","article-title":"Inflammation and adaptive immunity in Parkinson\u2019s disease","volume":"2","author":"Mosley","year":"2012","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00421","article-title":"A synthetic agonist to vasoactive intestinal peptide receptor-2 induces regulatory T cell neuroprotective activities in models of Parkinson\u2019s disease","volume":"13","author":"Mosley","year":"2019","journal-title":"Frontiers in Cellular Neuroscience."},{"key":"10.1016\/j.nbd.2020.104760_bb0535","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s13311-013-0182-9","article-title":"alpha-Synuclein and mitochondria: partners in crime?","volume":"10","author":"Nakamura","year":"2013","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.nbd.2020.104760_bb0540","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM199106203242504","article-title":"Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer","volume":"324","author":"Nemunaitis","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0545","first-page":"49","article-title":"Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy","volume":"7","author":"Nemunaitis","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.nbd.2020.104760_bb0550","first-page":"949","article-title":"Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation","volume":"15","author":"Nemunaitis","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.nbd.2020.104760_bb0555","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1017\/cjn.2016.290","article-title":"The international incidence of traumatic brain injury: a systematic review and meta-analysis","volume":"43","author":"Nguyen","year":"2016","journal-title":"Can J Neurol Sci."},{"key":"10.1016\/j.nbd.2020.104760_bb0560","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1447-0594.2011.00740.x","article-title":"Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson\u2019s disease","volume":"12","author":"Niwa","year":"2012","journal-title":"Geriatr Gerontol Int."},{"key":"10.1016\/j.nbd.2020.104760_bb0565","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3389\/fimmu.2018.01213","article-title":"Imbalance of circulating Th17 and regulatory T cells in Alzheimer\u2019s disease: a case control study","volume":"9","author":"Oberstein","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0570","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease (2009)","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2020.104760_bb0575","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.1523\/JNEUROSCI.2131-15.2015","article-title":"Selective VIP receptor agonists facilitate immune transformation for dopaminergic neuroprotection in MPTP-intoxicated mice","volume":"35","author":"Olson","year":"2015","journal-title":"J Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0580","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13311-016-0449-z","article-title":"Manganese-enhanced magnetic resonance imaging for detection of vasoactive intestinal peptide receptor 2 agonist therapy in a model of Parkinson\u2019s disease","volume":"13","author":"Olson","year":"2016","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.nbd.2020.104760_bb0585","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0306-8","article-title":"Dementia with Lewy bodies: an update and outlook","volume":"14","author":"Outeiro","year":"2019","journal-title":"Mol Neurodegener."},{"key":"10.1016\/j.nbd.2020.104760_bb0590","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.1100713","article-title":"Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells","volume":"187","author":"Penaranda","year":"2011","journal-title":"J Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0595","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nm1749","article-title":"CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells","volume":"14","author":"Perruche","year":"2008","journal-title":"Nat Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0600","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2015.10.013","article-title":"Innate and adaptive immune response in stroke: focus on epigenetic regulation","volume":"289","author":"Picascia","year":"2015","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0605","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/alzrt214","article-title":"Propagation of tau pathology in Alzheimer\u2019s disease: identification of novel therapeutic targets","volume":"5","author":"Pooler","year":"2013","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.nbd.2020.104760_bb0610","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/cn500149w","article-title":"Deciphering the function and regulation of microRNAs in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"5","author":"Qiu","year":"2014","journal-title":"ACS Chem Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0615","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson's disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.nbd.2020.104760_bb0620","doi-asserted-by":"crossref","first-page":"32460","DOI":"10.1074\/jbc.M910433199","article-title":"Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite","volume":"275","author":"Reiter","year":"2000","journal-title":"J Biol Chem."},{"key":"10.1016\/j.nbd.2020.104760_bb0625","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0074-7742(07)82016-2","article-title":"Oxidative stress and the pathogenesis of neurodegenerative disorders","volume":"82","author":"Reynolds","year":"2007","journal-title":"Int Rev Neurobiol."},{"key":"10.1016\/j.nbd.2020.104760_bb0630","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.nbd.2020.104760_bb0635","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0640","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J Immunol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104760_bb0645","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5607\/en.2011.20.1.1","article-title":"MAO-inhibitors in Parkinson's disease","volume":"20","author":"Riederer","year":"2011","journal-title":"Exp Neurobiol."},{"key":"10.1016\/j.nbd.2020.104760_bb0650","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/tri.12909","article-title":"Treg therapy in transplantation: a general overview","volume":"30","author":"Romano","year":"2017","journal-title":"Transpl Int."},{"key":"10.1016\/j.nbd.2020.104760_bb0655","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrneurol.2013.22","article-title":"Changing patterns in the epidemiology of traumatic brain injury","volume":"9","author":"Roozenbeek","year":"2013","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0660","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.V86.2.457.bloodjournal862457","article-title":"A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)","volume":"86","author":"Rowe","year":"1995","journal-title":"Blood."},{"key":"10.1016\/j.nbd.2020.104760_bb0665","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1039\/C6MB00699J","article-title":"Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis","volume":"13","author":"Roy","year":"2017","journal-title":"Mol Biosyst."},{"key":"10.1016\/j.nbd.2020.104760_bb0670","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0675","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","article-title":"Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer\u2019s disease","volume":"25","author":"Saresella","year":"2011","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.nbd.2020.104760_bb0680","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J Neuroimmune Pharmacol."},{"key":"10.1016\/j.nbd.2020.104760_bb0685","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1474-4422(05)70098-3","article-title":"Entacapone in the treatment of Parkinson\u2019s disease","volume":"4","author":"Schrag","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0690","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0561-x","article-title":"Sporadic Parkinson\u2019s disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs","volume":"6","author":"Schulze","year":"2018","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.nbd.2020.104760_bb0695","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-018-0255-7","article-title":"Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson\u2019s disease","volume":"13","author":"Schutt","year":"2018","journal-title":"Mol Neurodegener."},{"key":"10.1016\/j.nbd.2020.104760_bb0700","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jnen\/nly024","article-title":"Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo","volume":"77","author":"Scudamore","year":"2018","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0705","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0710","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson\u2019s disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic Biol Med."},{"key":"10.1016\/j.nbd.2020.104760_bb0715","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.185.8.1413","article-title":"Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy","volume":"185","author":"Smith","year":"1997","journal-title":"J Exp Med."},{"issue":"123\u2013131","key":"10.1016\/j.nbd.2020.104760_bb0720","article-title":"Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease","volume":"23","author":"Sommer","year":"2018","journal-title":"Cell Stem Cell."},{"key":"10.1016\/j.nbd.2020.104760_bb0725","doi-asserted-by":"crossref","first-page":"18344","DOI":"10.1074\/jbc.M000206200","article-title":"Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies","volume":"275","author":"Souza","year":"2000","journal-title":"J Biol Chem."},{"key":"10.1016\/j.nbd.2020.104760_bb0730","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000328636","article-title":"Neuropeptides as pleiotropic modulators of the immune response","volume":"94","author":"Souza-Moreira","year":"2011","journal-title":"Neuroendocrinology."},{"key":"10.1016\/j.nbd.2020.104760_bb0735","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1089\/ars.2009.2460","article-title":"Innate and adaptive immunity for the pathobiology of Parkinson\u2019s disease","volume":"11","author":"Stone","year":"2009","journal-title":"Antioxid Redox Signal."},{"key":"10.1016\/j.nbd.2020.104760_bb0740","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson\u2019s disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nbd.2020.104760_bb0745","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson\u2019s disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2020.104760_bb0750","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat Rev Neurosci."},{"key":"10.1016\/j.nbd.2020.104760_bb0755","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpara.2004.10.020","article-title":"Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii","volume":"35","author":"Suzuki","year":"2005","journal-title":"Int J Parasitol."},{"key":"10.1016\/j.nbd.2020.104760_bb0760","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3233\/JAD-141134","article-title":"Epidemiological and economic burden of Alzheimer\u2019s disease: a systematic literature review of data across Europe and the United States of America","volume":"43","author":"Takizawa","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104760_bb0765","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.nbd.2020.104760_bb0770","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nbd.2020.104760_bb0775","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1471-4159.2006.04315.x","article-title":"Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson\u2019s disease","volume":"100","author":"Thomas","year":"2007","journal-title":"J Neurochem."},{"key":"10.1016\/j.nbd.2020.104760_bb0780","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1212\/NXI.0000000000000465","article-title":"Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study","volume":"5","author":"Thonhoff","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.nbd.2020.104760_bb0785","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J Neural Transm (Vienna)."},{"key":"10.1016\/j.nbd.2020.104760_bb0790","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cei.12978","article-title":"Regulatory T cells: tolerance induction in solid organ transplantation","volume":"189","author":"Vaikunthanathan","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0795","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170157","article-title":"Combining radiotherapy with immunotherapy: the past, the present and the future","volume":"90","author":"Van Limbergen","year":"2017","journal-title":"Br J Radiol."},{"key":"10.1016\/j.nbd.2020.104760_bb0800","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1517\/14712598.7.4.461","article-title":"Tuning inflammation with anti-inflammatory neuropeptides","volume":"7","author":"Varela","year":"2007","journal-title":"Expert Opin Biol Ther."},{"key":"10.1016\/j.nbd.2020.104760_bb0805","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1021\/bi9909445","article-title":"Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase","volume":"38","author":"Viner","year":"1999","journal-title":"Biochemistry."},{"key":"10.1016\/j.nbd.2020.104760_bb0810","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2020.104760_bb0815","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nrd3031","article-title":"Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells","volume":"8","author":"Wang","year":"2009","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.nbd.2020.104760_bb0820","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/pds.2169","article-title":"The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients","volume":"21","author":"Wawruch","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.nbd.2020.104760_bb0825","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res."},{"key":"10.1016\/j.nbd.2020.104760_bb0830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0065-2776(08)00802-X","article-title":"CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes","volume":"100","author":"You","year":"2008","journal-title":"Adv Immunol."},{"key":"10.1016\/j.nbd.2020.104760_bb0835","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/glia.20532","article-title":"Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein","volume":"55","author":"Zhang","year":"2007","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2020.104760_bb0840","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/aps.2017.49","article-title":"Reassessment of subacute MPTP-treated mice as animal model of Parkinson\u2019s disease","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol Sin."},{"issue":"Suppl. 4","key":"10.1016\/j.nbd.2020.104760_bb0845","first-page":"160S","article-title":"Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion","volume":"51","author":"Zou","year":"2011","journal-title":"Transfusion."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120300358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120300358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:17:49Z","timestamp":1760851069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120300358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":169,"alternative-id":["S0969996120300358"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104760","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy for Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104760"}}